arrow
D

Diederick E. Grobbee

Utrecht University
H指数:162
被引数:11.8万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Sodium Content of Street and Restaurant Foods in Nigeria: A Multilevel Analysis of Food System Determinants

尼日利亚街头食品和餐馆食品的钠含量:食品系统决定因素的多层次分析

2026-08-110
OAAI
Sample size considerations to assess sex-related treatment effects

样本量考虑以评估性别相关的治疗效果

2026-01-012
PRE
Determinants, barriers, and facilitators of healthcare access for patients with hypertension in rural Ghana: applying the Andersen-Newman model of healthcare utilization

高血压患者医疗可及性的决定因素、障碍与促进因素:以加纳农村地区为例,应用Andersen-Newman医疗利用模型

2025-12-310
PRE
Machine learning-enabled systematic review on coded healthcare data in heart failure research

基于机器学习的系统性综述:心力衰竭研究中编码医疗数据的分析

2025-11-010
OAAI
Post-COVID-19 condition in individuals infected with SARS-CoV-2 in autumn 2023 in the Netherlands: a prospective cohort study with pre- and post-infection data

2023年秋季荷兰感染SARS-CoV-2个体的后COVID-19状态:一项具有感染前后数据的前瞻性队列研究

2025-10-060
OAAI
Selecting and Preparing Clinical Sites for the Successful Conduct of Decentralized Clinical Trial Activities–Findings From the Trials@Home RADIAL Proof-of-Concept Trial

选择和准备临床站点以成功开展去中心化临床试验活动——来自 Trials@Home RADIAL 验证性试验的发现

2025-10-010
OAAI
Recruiting and Consenting Decentralized Clinical Trial Participants—Learnings from the Trials@Home RADIAL Proof-of-Concept Trial

招募并征得分散式临床试验参与者的同意——来自 Trials@Home RADIAL 概念验证试验的经验教训

2025-09-040
OAAI
Bringing Trial Activities to Participants—The Trials@Home RADIAL Proof-of-Concept Trial Investigating Decentralization of Trials

将试验活动带给参与者—— Trials@Home RADIAL 概念验证试验研究试验的去中心化

2025-09-010
OAAI
Why and how do we perform physical examination(s) in clinical trials? A use case of drug intervention trials in type 2 diabetes mellitus

为什么以及如何我们在临床试验中进行体格检查?一个关于药物干预试验在2型糖尿病中的应用案例

2025-09-010
OAAI
Increasing Retention in a Large-Scale Decentralized Clinical Trial: Learnings From the COVID-RED Trial

提高大规模去中心化临床试验中的受试者留存率:来自COVID-RED试验的经验

2025-09-010
OAAI
Pharmacological treatment options for metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes mellitus: A systematic review

2型糖尿病患者代谢功能障碍相关脂肪性肝病的药物治疗选择: 系统评价

2025-02-120
OA